Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen ...
Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose ...
In Lubbock, residents face life's hiccups with humor, lighting candles for power outages and embracing the outdoors when the ...
FAT jabs have worked for millions but a new study warns users may need to stay with the pricey drugs for life – or risk ...
Potential side effects caused by the popular exercise supplement creatine include weight gain, nausea, diarrhea, muscle ...
Panelists discuss how real-world adherence to loading doses and thoughtful switching or reloading strategies can optimize durability and outcomes, particularly in undertreated patients. This segment ...